Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times

10.1016/j.parkreldis.2010.11.010

Saved in:

Bibliographic Details
Main Authors:	Zhao, Y.J., Wee, H.L., Au, W.L., Seah, S.H., Luo, N., Li, S.C., Tan, L.C.S.
Other Authors:	EPIDEMIOLOGY & PUBLIC HEALTH
Format:	Article
Published:	2014
Subjects:	Hoehn and Yahr stage Parkinson's disease Progression Selegiline
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/53157
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-53157
record_format	dspace
spelling	sg-nus-scholar.10635-531572023-10-26T08:03:05Z Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times Zhao, Y.J. Wee, H.L. Au, W.L. Seah, S.H. Luo, N. Li, S.C. Tan, L.C.S. EPIDEMIOLOGY & PUBLIC HEALTH PHARMACY Hoehn and Yahr stage Parkinson's disease Progression Selegiline 10.1016/j.parkreldis.2010.11.010 Parkinsonism and Related Disorders 17 3 194-197 PRDIF 2014-05-19T02:54:57Z 2014-05-19T02:54:57Z 2011-03 Article Zhao, Y.J., Wee, H.L., Au, W.L., Seah, S.H., Luo, N., Li, S.C., Tan, L.C.S. (2011-03). Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times. Parkinsonism and Related Disorders 17 (3) : 194-197. ScholarBank@NUS Repository. https://doi.org/10.1016/j.parkreldis.2010.11.010 13538020 http://scholarbank.nus.edu.sg/handle/10635/53157 000288475100012 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Hoehn and Yahr stage Parkinson's disease Progression Selegiline
spellingShingle	Hoehn and Yahr stage Parkinson's disease Progression Selegiline Zhao, Y.J. Wee, H.L. Au, W.L. Seah, S.H. Luo, N. Li, S.C. Tan, L.C.S. Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times
description	10.1016/j.parkreldis.2010.11.010
author2	EPIDEMIOLOGY & PUBLIC HEALTH
author_facet	EPIDEMIOLOGY & PUBLIC HEALTH Zhao, Y.J. Wee, H.L. Au, W.L. Seah, S.H. Luo, N. Li, S.C. Tan, L.C.S.
format	Article
author	Zhao, Y.J. Wee, H.L. Au, W.L. Seah, S.H. Luo, N. Li, S.C. Tan, L.C.S.
author_sort	Zhao, Y.J.
title	Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times
title_short	Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times
title_full	Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times
title_fullStr	Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times
title_full_unstemmed	Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times
title_sort	selegiline use is associated with a slower progression in early parkinson's disease as evaluated by hoehn and yahr stage transition times
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/53157
_version_	1781411855383658496

Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times

Similar Items